What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Gene
Bruce L. Miller focuses on Frontotemporal dementia, Dementia, Pathology, Alzheimer's disease and Neuroscience.
Particularly relevant to Semantic dementia is his body of work in Frontotemporal dementia.
The concepts of his Semantic dementia study are interwoven with issues in Primary progressive aphasia, Progressive nonfluent aphasia and Aphasia.
The various areas that Bruce L. Miller examines in his Dementia study include Developmental psychology, Psychiatry, Disinhibition and Amyloid.
In his research on the topic of Pathology, Cerebrospinal fluid and Tau protein is strongly related with Central nervous system disease.
His Alzheimer's disease study combines topics from a wide range of disciplines, such as Positron emission tomography, Apolipoprotein E and Age of onset.
His most cited work include:
- Frontotemporal lobar degeneration A consensus on clinical diagnostic criteria (4253 citations)
- Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis (4135 citations)
- Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) Report of the consortium on DLB international workshop (3554 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Frontotemporal dementia, Dementia, Neuroscience, Disease and Pathology.
His Frontotemporal dementia research is multidisciplinary, relying on both Alzheimer's disease, Psychiatry and Atrophy.
His Dementia research includes themes of Developmental psychology, Neuropsychology and Degenerative disease.
His Pathology research incorporates elements of White matter and Magnetic resonance imaging.
His Primary progressive aphasia research includes elements of Aphasia and Audiology.
The various areas that Bruce L. Miller examines in his Internal medicine study include Endocrinology and Cardiology.
He most often published in these fields:
- Frontotemporal dementia (34.37%)
- Dementia (28.06%)
- Neuroscience (21.53%)
What were the highlights of his more recent work (between 2017-2021)?
- Frontotemporal dementia (34.37%)
- Dementia (28.06%)
- Disease (19.67%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Frontotemporal dementia, Dementia, Disease, Internal medicine and Neuroscience.
His Frontotemporal dementia research integrates issues from Progressive supranuclear palsy and Atrophy.
His research in Dementia intersects with topics in Cognition, Cognitive impairment, Gerontology and Cohort.
Disease is a subfield of Pathology that Bruce L. Miller investigates.
His Internal medicine study combines topics from a wide range of disciplines, such as Endocrinology and Oncology.
His work deals with themes such as Semantic memory, Temporal lobe, Aphasia and Audiology, which intersect with Primary progressive aphasia.
Between 2017 and 2021, his most popular works were:
- Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated (183 citations)
- Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector (131 citations)
- Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration. (123 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Gene
His primary areas of study are Frontotemporal dementia, Dementia, Disease, Internal medicine and Frontotemporal lobar degeneration.
His Frontotemporal dementia research is multidisciplinary, incorporating elements of Tau protein, Neurodegeneration and Atrophy.
The concepts of his Dementia study are interwoven with issues in Neurology, Cognition, Cognitive impairment and Pediatrics.
His study in Disease is interdisciplinary in nature, drawing from both Positron emission tomography, Neuroscience and Depression.
Bruce L. Miller interconnects Endocrinology and Oncology in the investigation of issues within Internal medicine.
His Frontotemporal lobar degeneration study combines topics in areas such as Asymptomatic and Gene.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
